Merosin deficient congenital muscular dystrophy: genes and variants
Explore variant evidence for Merosin deficient congenital muscular dystrophy across 1 analyzed protein (LAMA2). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 58 variants of uncertain significance and 54 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Merosin deficient congenital muscular dystrophy
LAMA2: Laminin subunit alpha-2
It links cells to surrounding extracellular matrix through dystroglycan and integrins. Biallelic loss-of-function variants cause LAMA2-related muscular dystrophy, ranging from severe congenital disease to later-onset limb-girdle weakness.
9 ClinVar pathogenic / likely pathogenic and 112 uncertain variants in LAMA2 have source records linked to Merosin deficient congenital muscular dystrophy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Merosin deficient congenital muscular dystrophy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LAMA2 C1079R | 1079 | Laminin EGF-like 12 | Pathogenic / likely pathogenic (★★) |
| LAMA2 M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| LAMA2 H2627Q | 2627 | Laminin G-like 3 | Pathogenic / likely pathogenic (★★) |
| LAMA2 R1508K | 1508 | Laminin EGF-like 16 | Pathogenic / likely pathogenic (★★) |
| LAMA2 L243P | 243 | Laminin N-terminal | Pathogenic / likely pathogenic (★) |
| LAMA2 G284R | 284 | Laminin N-terminal | Pathogenic / likely pathogenic (★) |
| LAMA2 E722K | 722 | Laminin IV type A 1 | Pathogenic / likely pathogenic |
| LAMA2 T821P | 821 | Laminin EGF-like 7 | Pathogenic / likely pathogenic |
| LAMA2 I2761T | 2761 | Pathogenic / likely pathogenic |
Which prediction tools work for Merosin deficient congenital muscular dystrophy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 79 out of 100
- CATVariant: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 73 out of 100
- MetaLR: 72 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 70 out of 100
- CADD: 69 out of 100
- phyloP: 69 out of 100
- PolyPhen-2: 64 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phastCons: 56 out of 100
Same protein, different disease
- LAMA2-related muscular dystrophy also has ClinVar records linked to LAMA2 variants; they fall mostly in different places as the Merosin deficient congenital muscular dystrophy variants (11 pathogenic / likely pathogenic).
Diseases related to Merosin deficient congenital muscular dystrophy
- Limb-girdle muscular dystrophy, also linked to LAMA2
- LAMA2-related muscular dystrophy, also linked to LAMA2
- Muscular dystrophy due to LMNA mutation, also linked to LAMA2
- Muscular dystrophy, also linked to LAMA2
Frequently asked questions
Which genes have records linked to Merosin deficient congenital muscular dystrophy?
This view contains 1 analyzed proteins: LAMA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 58 variants of uncertain significance and 54 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 128 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center